Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium and transmitted principally through the bites of infected female Anopheles mosquitoes. Several Plasmodium species infect humans, with Plasmodium falciparum being particularly important because it can cause severe and rapidly progressive disease. Plasmodium vivax, Plasmodium ovale and Plasmodium malariae also cause human malaria, while Plasmodium knowlesi can cause zoonotic malaria in parts of Southeast Asia. The disease is therefore not caused by a single organism, and species identification can influence clinical management because their life cycles and relapse patterns differ.
The Malaria parasite has a complex life cycle involving both mosquitoes and humans. During a mosquito bite, infectious sporozoites enter the bloodstream and travel to the liver, where they invade hepatocytes. After development in the liver, parasites are released into the bloodstream and invade red blood cells, undergoing repeated cycles of growth and multiplication. Rupture of infected erythrocytes contributes to fever and other systemic manifestations. Some parasites differentiate into sexual forms called gametocytes, which can be taken up by another mosquito and continue the life cycle within the insect. This alternation between vertebrate and mosquito hosts is central to malaria transmission.
Clinical manifestations of Malaria commonly include fever, chills, headache, weakness and muscle aches, but presentation can vary considerably. Severe malaria can involve impaired consciousness, seizures, respiratory complications, severe anaemia, metabolic abnormalities, kidney injury or other organ dysfunction. Plasmodium falciparum is particularly associated with severe disease because infected red blood cells can adhere to vascular endothelium and become sequestered in small blood vessels. Delayed diagnosis and treatment can therefore lead to rapid deterioration. Any febrile illness after travel to a malaria-endemic region can require urgent medical assessment because symptoms alone cannot reliably exclude malaria.
Diagnosis generally involves detecting Plasmodium parasites or parasite-derived material in blood. Microscopy can identify parasites and sometimes determine species and parasite density, while rapid diagnostic tests detect specific parasite antigens. Molecular tests can provide additional sensitivity and species information where available. Repeated testing may be necessary when clinical suspicion remains high despite an initially negative result because parasite levels can vary over time. Accurate diagnosis matters because malaria can deteriorate rapidly and because treatment differs according to parasite species, geographic acquisition, resistance patterns and severity.
Antimalarial treatment depends on the species, geographical location in which infection was acquired, drug-resistance patterns, clinical severity and patient-specific factors. Severe malaria requires urgent treatment, often with intravenous therapy and intensive supportive management. Uncomplicated infections are treated with appropriate oral antimalarial regimens selected according to current regional recommendations. Plasmodium vivax and Plasmodium ovale can form dormant liver stages known as hypnozoites, which can cause later relapses; eliminating these stages requires additional treatment when appropriate. This distinction means that clearing parasites from the bloodstream is not always equivalent to eliminating every clinically relevant stage of infection.
Prevention of Malaria combines personal protection against mosquito bites with, where appropriate, chemoprevention or vaccination. Measures can include insecticide-treated bed nets, suitable clothing, repellents, screened accommodation and vector-control programmes. Travellers to malaria-risk regions may be advised to take preventive medicines selected according to destination and individual circumstances. Vaccines have also become an important public-health tool for children in certain malaria-endemic settings, although vaccination does not replace other preventive measures. Control programmes additionally target mosquitoes and transmission at community level.
Malaria has had major historical effects on populations, economies and military operations in tropical and subtropical regions. Its distribution is strongly influenced by mosquito ecology, climate, geography, housing, public-health infrastructure and access to effective treatment. Resistance to antimalarial medicines and insecticides remains a major challenge because evolutionary selection can reduce the effectiveness of interventions. Malaria elimination is consequently more difficult than simply providing medication: sustained surveillance, vector control, diagnosis, treatment, prevention and health-system capacity must work together, and the relevant strategy differs between regions.
A common misconception is that Malaria is synonymous with any mosquito-borne fever. It is specifically caused by Plasmodium parasites and is transmitted principally through infected Anopheles mosquitoes. Another misconception is that recovery from one infection always provides complete protection against future infection; immunity can be complex and partial, particularly in endemic populations. Malaria is also not restricted to one continent or one parasite species. Its potentially rapid progression, the existence of multiple parasite life stages and the emergence of drug and insecticide resistance make early diagnosis and appropriate prevention particularly important for people exposed to malaria transmission.
